Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Castration Resistant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01833208
What this trial is testing

Radiation Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Receiving Sipuleucel-T

Who this might be right for
Hormone-Resistant Prostate CancerMetastatic Malignant Neoplasm in the BoneRecurrent Prostate Carcinoma+1 more
Roswell Park Cancer Institute 15
Testing effectiveness (Phase 2)Study completedNCT01543776
What this trial is testing

Food Effect Study of Abiraterone Acetate for Treatment of Patients With Castration-Resistant Prostate Cancer

Who this might be right for
Castration-resistant Prostate CancerStage IV Prostate Cancer
University of Chicago 72
Testing effectiveness (Phase 2)Ended earlyNCT02378870
What this trial is testing

A Phase IIb Study to Evaluate Efficacy and Tolerability of ODX (Osteodex) in Metastatic CRPC

Who this might be right for
Prostate Cancer Metastatic
DexTech Medical AB 3
Not applicableStudy completedNCT01858441
What this trial is testing

Pharmacogenetic Study in Castration-resistant Prostate Cancer Patients Treated With Abiraterone Acetate

Who this might be right for
Pharmacogenetic Study
Centre Antoine Lacassagne 148
Early research (Phase 1)Study completedNCT02215096
What this trial is testing

Dose-finding Study of GSK2636771 When Administered in Combination With Enzalutamide in Male Subjects With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Neoplasms
GlaxoSmithKline 37
Testing effectiveness (Phase 2)Ended earlyNCT03442556
What this trial is testing

Docetaxel, Carboplatin, and Rucaparib Camsylate in Treating Patients With Metastatic Castration Resistant Prostate Cancer With Homologous Recombination DNA Repair Deficiency

Who this might be right for
ATM Gene MutationBRCA1 Gene MutationBRCA2 Gene Mutation+7 more
University of Washington 18
Early research (Phase 1)Study completedNCT02705469
What this trial is testing

ZEN003694 in Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
Zenith Epigenetics 44
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06827080
What this trial is testing

Study on the Safety, Tolerability, and Preliminary Efficacy of 161Tb-NYM032 in Patients with Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer, MCRPCCancer
Zhengguo Chen 15
Not applicableStudy completedNCT02237170
What this trial is testing

Immune Monitoring on Sipuleucel-T

Who this might be right for
Prostate Cancer
Icahn School of Medicine at Mount Sinai 36
Testing effectiveness (Phase 2)Ended earlyNCT05501548
What this trial is testing

Phase II Study of PARP Inhibitor Olaparib and IV Ascorbate in Castration Resistant Prostate Cancer

Who this might be right for
Prostate CancerCastration-resistant Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 4
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07793435
What this trial is testing

A Phase 1/2 Trial of ADI-212 in mCRPC

Who this might be right for
Prostate Cancer Metastatic
Adicet Therapeutics 12
Testing effectiveness (Phase 2)Study completedNCT01812746
What this trial is testing

Determine the Safety and Efficacy of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension), Administered to Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
CRPCProstate Cancer
BIND Therapeutics 42
Testing effectiveness (Phase 2)Study completedNCT03101046
What this trial is testing

Treatment of Metastatic Castrate Resistant Prostate Cancer Patients According to Circulating Tumor Cells Kinetic

Who this might be right for
Prostate CarcinomaCastration-resistant Prostate CancerCirculating Tumor Cells+1 more
UNICANCER 40
Testing effectiveness (Phase 2)Study completedNCT01091103
What this trial is testing

Determine Effect of Enzalutamide (MDV3100) on the Androgen Signaling Pathway in Correlation With the Anti-tumor Effects of Enzalutamide

Who this might be right for
Metastatic Progressive Castration-resistant Prostate Cancer
Pfizer 60
Testing effectiveness (Phase 2)Ended earlyNCT05917470
What this trial is testing

A Clinical Study of ONCT-534 in Subjects With Metastatic Castration-resistant Prostate Cancer.

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Oncternal Therapeutics, Inc 21
Early research (Phase 1)Study completedNCT06377683
What this trial is testing

Clinical Evaluation of 177Lu-DansyI-PSMA (LNC1011) in Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer, mCRPC
The First Affiliated Hospital of Xiamen University 8
Large-scale testing (Phase 3)Looking for participantsNCT06629779
What this trial is testing

Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
Pfizer 900
Early research (Phase 1)Study completedNCT01186484
What this trial is testing

Phase 1 Study of Abiraterone Acetate in Castration-resistant Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Janssen Pharmaceutical K.K. 27
Testing effectiveness (Phase 2)Study completedNCT02346526
What this trial is testing

A Biomarker Study of Standard-of-care Radium-223 Chloride for Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Prostate CancerCastration-resistant Prostate CancerCastration-resistant Prostate Cancer Metastatic to Bone
Massachusetts General Hospital 22
Large-scale testing (Phase 3)Looking for participantsNCT06585007
What this trial is testing

Metastasis-directed Therapy in Oligoprogressive Castration-refractory Prostate Cancer

Who this might be right for
Castration-resistant Prostate CancerOligoprogressive
Universitaire Ziekenhuizen KU Leuven 246
Next Page